130 related articles for article (PubMed ID: 9788408)
21. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
22. Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath technique.
Fransson P; Bergström P; Löfroth PO; Widmark A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):430-8. PubMed ID: 16904846
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
Koelbl O; Schwab F; Bratengeier K; Vordermark D; Flentje M
Strahlenther Onkol; 2005 Feb; 181(2):108-12. PubMed ID: 15702299
[TBL] [Abstract][Full Text] [Related]
24. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer.
Mubata CD; Bidmead AM; Ellingham LM; Thompson V; Dearnaley DP
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):221-31. PubMed ID: 9422580
[TBL] [Abstract][Full Text] [Related]
25. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland.
Mohan DS; Kupelian PA; Willoughby TR
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):575-80. PubMed ID: 10701736
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
[TBL] [Abstract][Full Text] [Related]
27. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy.
Carl J; Lund B; Larsen EH; Nielsen J
Radiother Oncol; 2006 Feb; 78(2):199-206. PubMed ID: 16413623
[TBL] [Abstract][Full Text] [Related]
29. [Conformal radiotherapy of prostate carcinoma--procedure description].
Erak M; Bugarcić B; Erak D; Arandelović D; Nad I; Tesanović D
Med Pregl; 2011; 64(1-2):51-4. PubMed ID: 21548269
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique.
Poulsen PR; Fokdal L; Petersen J; Høyer M
Radiother Oncol; 2007 Apr; 83(1):25-30. PubMed ID: 17386952
[TBL] [Abstract][Full Text] [Related]
31. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
[TBL] [Abstract][Full Text] [Related]
32. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.
Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K
Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization system.
Wang L; Jacob R; Chen L; Ma C; Movsas B; Feigenberg S; Konski A
J Appl Clin Med Phys; 2004; 5(2):18-28. PubMed ID: 15738910
[TBL] [Abstract][Full Text] [Related]
34. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
Agoston P; Major T; Somogyi A; Szûcs M; Danczig A; Lövey J; Polgár C; Fodor J; Németh G; Kásler M
Magy Onkol; 2004; 48(1):81-8. PubMed ID: 15105901
[TBL] [Abstract][Full Text] [Related]
35. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
Harsolia A; Vargas C; Yan D; Brabbins D; Lockman D; Liang J; Gustafson G; Vicini F; Martinez A; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1100-9. PubMed ID: 17967304
[TBL] [Abstract][Full Text] [Related]
36. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers.
Engels B; Soete G; Verellen D; Storme G
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):388-91. PubMed ID: 19056185
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.
Teh BS; Mai WY; Uhl BM; Augspurger ME; Grant WH; Lu HH; Woo SY; Carpenter LS; Chiu JK; Butler EB
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):705-12. PubMed ID: 11172952
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
[TBL] [Abstract][Full Text] [Related]
39. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
Mott JH; Livsey JE; Logue JP
Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
[TBL] [Abstract][Full Text] [Related]
40. Dose-escalated 3D conformal radiotherapy in prostate cancer.
Malone S
Expert Rev Anticancer Ther; 2004 Aug; 4(4):663-8. PubMed ID: 15270669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
